Kapp-Schwoerer, Silke;Weber, Daniela;Corbacioglu, Andrea;Gaidzik, Verena I;Paschka, Peter;Krönke, Jan;Theis, Frauke;Rücker, Frank G;Teleanu, Maria-Veronica;Panina, Ekaterina;Jahn, Nikolaus;Herzig, Julia;Kubanek, Lena;Schrade, Anika;Göhring, Gudrun;Fiedler, Walter;Kindler, Thomas;Schroeder, Thomas;Mayer, Karin T;Lübbert, Michael;Wattad, Mohammed;Götze, Katharina S;Horst, Heinz A;Koller, Elisabeth;Wulf, Gerald;Schleicher, Jan;Bentz, Martin;Krauter, Jürgen;Bullinger, Lars;Krzykalla, Julia;Benner, Axel;Schlenk, Richard F;Thol, Felicitas;Heuser, Michael;Ganser, Arnold;Döhner, Hartmut;Döhner, Konstanze.Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial..Blood.2020.136.26.3041-3050